Precision BioSciences Inc. (DTIL) PT Lowered to $7 at Stifel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- S&P 500 futures steady after midterm rally; Nasdaq lags on chip weakness
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts DTIL Hot Sheet
Price: $8.12 --0%
Rating Summary:
10 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 30 | New: 5
Rating Summary:
10 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 30 | New: 5
Join SI Premium – FREE
Stifel analyst Benjamin J. Burnett lowered the price target on Precision BioSciences Inc. (NASDAQ: DTIL) to $7.00 (from $9.00) while maintaining a Buy rating.
You May Also Be Interested In
- Precision BioSciences (DTIL) Tops Q3 EPS by 56c
- Magnite (MGNI) PT Raised to $30 at Scotiabank
- Chime Financial (CHYM) PT Raised to $44 at Scotiabank
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
